학술논문
One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses
Document Type
Artikel
Author
Source
Arthritis care & research. 74(5):748-758
Subject
Language
English
English
English
ISSN
2151-4658